• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名糖尿病患者因使用艾考糊精腹膜透析液继发严重低血糖。

Significant hypoglycemia secondary to icodextrin peritoneal dialysate in a diabetic patient.

作者信息

Kroll Henry R, Maher Thomas R

机构信息

Department of Anesthesiology, Henry Ford Hospital, Detroit, Michigan 48202-9888, USA.

出版信息

Anesth Analg. 2007 Jun;104(6):1473-4, table of contents. doi: 10.1213/01.ane.0000264007.46873.0f.

DOI:10.1213/01.ane.0000264007.46873.0f
PMID:17513644
Abstract

Icodextrin, a peritoneal dialysate commonly used in the renal failure patient with diabetes, may lead to an overestimation of blood glucose levels as determined by bedside glucometers. This spurious hyperglycemia can lead to significant morbidity if unrecognized. We describe a case of severe hypoglycemia caused by an unappreciated overestimation of blood glucose in a diabetic patient with concomitant chronic renal failure requiring peritoneal dialysis with icodextrin.

摘要

艾考糊精是一种常用于糖尿病肾衰竭患者的腹膜透析液,可能会导致床边血糖仪测定的血糖水平被高估。如果未被识别,这种假性高血糖可能会导致严重的发病率。我们描述了一例糖尿病合并慢性肾衰竭患者因未意识到血糖被高估而导致严重低血糖的病例,该患者需要使用艾考糊精进行腹膜透析。

相似文献

1
Significant hypoglycemia secondary to icodextrin peritoneal dialysate in a diabetic patient.一名糖尿病患者因使用艾考糊精腹膜透析液继发严重低血糖。
Anesth Analg. 2007 Jun;104(6):1473-4, table of contents. doi: 10.1213/01.ane.0000264007.46873.0f.
2
Masked hypoglycemia in the presence of icodextrin for peritoneal dialysis.在使用艾考糊精进行腹膜透析时出现的隐匿性低血糖。
J Emerg Med. 2013 Feb;44(2):e191-3. doi: 10.1016/j.jemermed.2012.02.037. Epub 2012 May 11.
3
Occult hypoglycemia in a diabetic patient on peritoneal dialysis.一名接受腹膜透析的糖尿病患者的隐匿性低血糖症。
Eur J Emerg Med. 2005 Dec;12(6):322-3. doi: 10.1097/00063110-200512000-00016.
4
Hypoglycemic coma in a diabetic patient on peritoneal dialysis due to interference of icodextrin metabolites with capillary blood glucose measurements.一名接受腹膜透析的糖尿病患者因艾考糊精代谢产物干扰毛细血管血糖测量而发生低血糖昏迷。
Diabetes Care. 2004 Sep;27(9):2279. doi: 10.2337/diacare.27.9.2279.
5
[Hypoglycaemic coma due to falsely elevated glucose values in a patient with diabetes mellitus and peritoneal dialysis].[糖尿病合并腹膜透析患者因血糖值假性升高导致的低血糖昏迷]
Ned Tijdschr Geneeskd. 2006 Jul 15;150(28):1574-6.
6
Icodextrin: an alternative peritoneal dialysis fluid.艾考糊精:一种替代性腹膜透析液。
Expert Opin Drug Metab Toxicol. 2008 Nov;4(11):1455-64. doi: 10.1517/17425255.4.11.1455.
7
[False measurement of glucose during dialysis with icodextrin].[使用艾考糊精进行透析期间葡萄糖的错误测量]
Tidsskr Nor Laegeforen. 2006 Sep 7;126(17):2268-70.
8
Avoidable iatrogenic hypoglycemia in patients on peritoneal dialysis: the risks of nonspecific glucose monitoring devices and drug-device interaction.腹膜透析患者中可避免的医源性低血糖:非特异性血糖监测设备及药物-设备相互作用的风险
J Patient Saf. 2014 Dec;10(4):218-21. doi: 10.1097/PTS.0b013e318299614e.
9
False elevations in blood glucose readings with use of icodextrin (extraneal) peritoneal dialysis solution.使用艾考糊精(Extraneal)腹膜透析液时血糖读数的假性升高。
CANNT J. 2009 Oct-Dec;19(4):37-8.
10
Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.使用基于艾考糊精和基于葡萄糖的透析液治疗的患者的腹膜炎症渗出标志物。
Adv Perit Dial. 2003;19:186-90.

引用本文的文献

1
Narrative Review of Glycemic Management in People With Diabetes on Peritoneal Dialysis.腹膜透析糖尿病患者血糖管理的叙述性综述
Kidney Int Rep. 2023 Feb 9;8(4):700-714. doi: 10.1016/j.ekir.2023.01.040. eCollection 2023 Apr.
2
Assessment of analytical performance of glucose meter in pediatric age group at tertiary care referral hospital.三级医疗转诊医院儿科年龄组血糖仪分析性能评估。
J Diabetes Metab Disord. 2017 Sep 13;16:38. doi: 10.1186/s40200-017-0318-2. eCollection 2017.
3
Icodextrin and spurious hyperglycemia in peritoneal dialysis patients: a hospital-wide attempt to prevent such errors.
腹膜透析患者中的艾考糊精与假性高血糖症:全院范围内预防此类错误的尝试。
Korean J Anesthesiol. 2017 Aug;70(4):479. doi: 10.4097/kjae.2017.70.4.479. Epub 2017 Apr 28.
4
Pharmacovigilance as a tool for safety and monitoring: a review of general issues and the specific challenges with end-stage renal failure patients.药物警戒作为安全与监测的工具:终末期肾衰竭患者的一般问题及特殊挑战综述
Drug Healthc Patient Saf. 2013 Apr 15;5:105-12. doi: 10.2147/DHPS.S43104. Print 2013.
5
Severe unrecognised hypoglycaemia presenting as pseudonormoglycaemia and unexplained coma in two patients with renal failure.两名肾衰竭患者出现严重未被识别的低血糖,表现为假性血糖正常和不明原因的昏迷。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2008.0416. Epub 2009 Feb 20.
6
Glucose meters: a review of technical challenges to obtaining accurate results.血糖仪:关于获取准确结果的技术挑战的综述
J Diabetes Sci Technol. 2009 Jul 1;3(4):971-80. doi: 10.1177/193229680900300446.
7
Hypoglycaemic coma due to falsely high point-of-care glucose measurements in an ICU-patient with peritoneal dialysis: a critical incidence report.一名接受腹膜透析的重症监护病房患者因即时检测血糖值假性升高导致低血糖昏迷:一份危急事件报告
Intensive Care Med. 2009 Mar;35(3):571-2. doi: 10.1007/s00134-008-1362-7. Epub 2008 Dec 5.